Company Overview

Update
Headquarters:
Kent
Funding:
$6M
Categories:
Biotechnology

Ziarco is a biotechnology company developing therapies for inflammatory and allergic diseases.

Description

Update

Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery. Ziarco has 4 major development programmes staffed by highly experienced drug development professionals.

Funding Rounds (1) - $6M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    Lombard House

    12-17 Upper Bridge Street, Offices 205-6, Canterbury

    Kent, CT1 2NF

    GBR